Companies in #Wet AMD

Found 2 companies operating in this sector.

Ollin Biosciences

Private

Ollin Biosciences is a clinical-stage ophthalmology company developing a next-generation anti-VEGF challenger to Regeneron's Eylea and Roche's Vabysmo for retinal disease. The company raised a $330M Series B in 2026 to fund pivotal Phase 3 trials of its lead asset.

Sector:Biotechnology / Ophthalmology / Anti-VEGF

HQ:South San Francisco, California, USA

View Profile →

Outlook Therapeutics

NASDAQ: OTLK ↗

Outlook Therapeutics is a ophthalmology company. See today's news for the latest developments.

Sector:Ophthalmology

HQ:Princeton, New Jersey, USA

View Profile →